Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells

European Journal of Clinical Pharmacology

Volumn 55, Issue 9, 1999, Pages 625-626

  Mueck, A O ^a   Seeger, H ^a   Lippert, T H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Endothelin secretion; Fluvastatin; Vascular endothelial cells

Indexed keywords

ATORVASTATIN; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY PREVENTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0032738612     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050683     Document Type: Article

References (6)

1. 1. Lennernäs H, Fager G (1997) Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Clin Pharmacokinet 32: 403-425
2. 2. Watts GF, Burke V (1996) Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues. Curr Opin Lipidol 7: 341-355
3. 3. Vaughan CJ, Murphy MB, Buckley BM (1996) Statins do more than just lower cholesterol. Lancet 348: 1079-1082
4. 4. Levin EL (1995) Endothelins. New Engl J Med 333: 356-363
5. 5. Plosker GL, Wagstaff AJ (1996) Fluvastatin - a review of its pharmacology and use in management of hypercholesterolaemia. Drugs 51: 433-459
6. 6. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, Lamas S (1998) Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719